These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 20601931)
1. Impaired Cd14 and Cd36 expression, bacterial clearance, and Toll-like receptor 4-Myd88 signaling in caveolin-1-deleted macrophages and mice. Tsai TH; Chen SF; Huang TY; Tzeng CF; Chiang AS; Kou YR; Lee TS; Shyue SK Shock; 2011 Jan; 35(1):92-9. PubMed ID: 20601931 [TBL] [Abstract][Full Text] [Related]
2. CD36 Differently Regulates Macrophage Responses to Smooth and Rough Lipopolysaccharide. Biedroń R; Peruń A; Józefowski S PLoS One; 2016; 11(4):e0153558. PubMed ID: 27073833 [TBL] [Abstract][Full Text] [Related]
3. The mechanism of LPS-induced HIV type I activation in transgenic mouse macrophages. Kadoki M; Choi BI; Iwakura Y Int Immunol; 2010 Jun; 22(6):469-78. PubMed ID: 20504885 [TBL] [Abstract][Full Text] [Related]
4. 34 kDa MOMP of Shigella flexneri promotes TLR2 mediated macrophage activation with the engagement of NF-kappaB and p38 MAP kinase signaling. Pore D; Mahata N; Pal A; Chakrabarti MK Mol Immunol; 2010 May; 47(9):1739-46. PubMed ID: 20347487 [TBL] [Abstract][Full Text] [Related]
5. Methods of in vitro macrophage maturation confer variable inflammatory responses in association with altered expression of cell surface dectin-1. Gersuk GM; Razai LW; Marr KA J Immunol Methods; 2008 Jan; 329(1-2):157-66. PubMed ID: 17997408 [TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 4 plays a role in macrophage phagocytosis during peritoneal sepsis. Anand RJ; Kohler JW; Cavallo JA; Li J; Dubowski T; Hackam DJ J Pediatr Surg; 2007 Jun; 42(6):927-32; discussion 933. PubMed ID: 17560196 [TBL] [Abstract][Full Text] [Related]
7. MyD88-independent activation of a novel actin-Cdc42/Rac pathway is required for Toll-like receptor-stimulated phagocytosis. Kong L; Ge BX Cell Res; 2008 Jul; 18(7):745-55. PubMed ID: 18542102 [TBL] [Abstract][Full Text] [Related]
8. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. Means TK; Lien E; Yoshimura A; Wang S; Golenbock DT; Fenton MJ J Immunol; 1999 Dec; 163(12):6748-55. PubMed ID: 10586073 [TBL] [Abstract][Full Text] [Related]
9. The diacylated lipopeptide FSL-1 enhances phagocytosis of bacteria by macrophages through a Toll-like receptor 2-mediated signalling pathway. Mae M; Iyori M; Yasuda M; Shamsul HM; Kataoka H; Kiura K; Hasebe A; Totsuka Y; Shibata K FEMS Immunol Med Microbiol; 2007 Apr; 49(3):398-409. PubMed ID: 17316370 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages. Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270 [TBL] [Abstract][Full Text] [Related]
11. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817 [TBL] [Abstract][Full Text] [Related]
12. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Roger T; David J; Glauser MP; Calandra T Nature; 2001 Dec 20-27; 414(6866):920-4. PubMed ID: 11780066 [TBL] [Abstract][Full Text] [Related]
13. CD14 is required for MyD88-independent LPS signaling. Jiang Z; Georgel P; Du X; Shamel L; Sovath S; Mudd S; Huber M; Kalis C; Keck S; Galanos C; Freudenberg M; Beutler B Nat Immunol; 2005 Jun; 6(6):565-70. PubMed ID: 15895089 [TBL] [Abstract][Full Text] [Related]
14. The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades. Björkbacka H; Fitzgerald KA; Huet F; Li X; Gregory JA; Lee MA; Ordija CM; Dowley NE; Golenbock DT; Freeman MW Physiol Genomics; 2004 Nov; 19(3):319-30. PubMed ID: 15367722 [TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes. Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620 [TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori. Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139 [TBL] [Abstract][Full Text] [Related]
17. The regulation of the expression of inducible nitric oxide synthase by Src-family tyrosine kinases mediated through MyD88-independent signaling pathways of Toll-like receptor 4. Lee JY; Lowell CA; Lemay DG; Youn HS; Rhee SH; Sohn KH; Jang B; Ye J; Chung JH; Hwang DH Biochem Pharmacol; 2005 Oct; 70(8):1231-40. PubMed ID: 16140274 [TBL] [Abstract][Full Text] [Related]
18. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance. Calvano JE; Agnese DM; Um JY; Goshima M; Singhal R; Coyle SM; Reddell MT; Kumar A; Calvano SE; Lowry SF Shock; 2003 Nov; 20(5):415-9. PubMed ID: 14560104 [TBL] [Abstract][Full Text] [Related]
19. Neisseria meningitidis can induce pro-inflammatory cytokine production via pathways independent from CD14 and toll-like receptor 4. Sprong T; van der Ley P; Steeghs L; Taw WJ; Verver-Janssen TJ; Netea MG; van der Meer JW; van Deuren M Eur Cytokine Netw; 2002; 13(4):411-7. PubMed ID: 12517725 [TBL] [Abstract][Full Text] [Related]
20. CD14 and TRIF govern distinct responsiveness and responses in mouse microglial TLR4 challenges by structural variants of LPS. Regen T; van Rossum D; Scheffel J; Kastriti ME; Revelo NH; Prinz M; Brück W; Hanisch UK Brain Behav Immun; 2011 Jul; 25(5):957-70. PubMed ID: 20951794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]